Literature DB >> 16361756

A case of bleomycin-induced acral erythema (AE) with eccrine squamous syringometaplasia (ESS) and summary of reports of AE with ESS in the literature.

Hiromi Tsuboi1, Kohzoh Yonemoto, Kensei Katsuoka.   

Abstract

Chemotherapy-induced acral erythema (AE) is primarily induced by hydroxyurea, methotrexate, and cytarabine, although there are rare reports of AE induced by combination chemotherapy containing bleomycin. It is thought that the accumulation of chemotherapeutic drugs in eccrine glands may cause eccrine squamous syringometaplasia (ESS), which is characterized by metaplasia and focal necrosis of the epithelium of the eccrine duct. ESS is occasionally detected in conjunction with AE, but such occurrences are relatively uncommon. This is the first report of AE with ESS induced by the administration of bleomycin alone. We also provide a summary of past cases of AE with ESS in the literature.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16361756     DOI: 10.1111/j.1346-8138.2005.tb00873.x

Source DB:  PubMed          Journal:  J Dermatol        ISSN: 0385-2407            Impact factor:   4.005


  1 in total

1.  A cross-sectional survey of methods for controling hand-foot syndrome in patients receiving capecitabine treatment.

Authors:  Shinya Suzuki; Shuichi Nawata; Yusuke Inada; Daisuke Sato; Junichi Kusano; Daisuke Ichikura; Kazuhiro Torigoe; Kazumi Ishitsuka; Fumiaki Sato; Hiroyasu Sakai; Tetsuro Yumoto
Journal:  Mol Clin Oncol       Date:  2018-08-02
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.